← All FR Documents
Notice

Center for Scientific Review; Notice of Closed Meetings

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, National Institutes of Health. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This notice communicates agency policy or guidance regarding applicable regulations.

Document Details

Document Number2025-18625
TypeNotice
PublishedSep 25, 2025
Effective Date-
RIN-
Docket ID-
Text FetchedYes

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

📋 Extracted Requirements 0 found

No extractable regulatory requirements found in this document. This is common for documents that:

  • Incorporate requirements by reference (IBR) to external documents
  • Are procedural notices without substantive obligations
  • Contain only preamble/explanation without regulatory text

Full Document Text (865 words · ~5 min read)

Text Preserved
<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>Center for Scientific Review; Notice of Closed Meetings</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; Translational Investigations of Pulmonary and Immunological Diseases. <E T="03">Date:</E> October 27-28, 2025. <E T="03">Time:</E> 10:00 a.m. to 7:30 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Carl White, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4835, <E T="03">carl.white@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; PAR Panel: Immune Oncology and Cancer Biomarker Research (R03). <E T="03">Date:</E> October 29, 2025. <E T="03">Time:</E> 1:00 p.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Robert F. Gahl, BS, Ph.D., Scientific Review Officer, Cancer Diagnosis, Prevention & Therapeutics Division of Translational and Clinical Sciences, Center for Scientific Review, National Cancer Institute, NIH Rockville, MD 20850, (240) 276-7869, <E T="03">robert.gahl@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; T32 and T35 Institutional Research Training Grants. <E T="03">Date:</E> November 4-5, 2025. <E T="03">Time:</E> 9:30 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Murali Ganesan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, <E T="03">murali.ganesan@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; PAR 23-077: Collaborative Program Grant for Multidisciplinary Teams (RM1). <E T="03">Date:</E> November 10, 2025. <E T="03">Time:</E> 10:00 a.m. to 4:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Sergei Ruvinov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892, 301-435-1180, <E T="03">ruvinser@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; Small Business: Respiratory Sciences. <E T="03">Date:</E> November 13-14, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:30 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Imoh S. Okon, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, 9609 Medical Center Drive, Suite 1E504, Bethesda, MD 20892, (301) 347-8881, <E T="03">imoh.okon@nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; Small Business: Cancer Diagnosis and Treatment (CDT). <E T="03">Date:</E> November 13-14, 2025. <E T="03">Time:</E> 9:30 a.m. to 7:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Asifa Haider, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 803C, Bethesda, MD 20892, (301) 480-2190, <E T="03">haidera2@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; Health Promotion Interventions: Research Scientist Development Award. <E T="03">Date:</E> November 14, 2025. <E T="03">Time:</E> 1:00 p.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Rebecca I Tinker, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20817, (301) 435-0637, <E T="03">tinkerri@csr.nih.gov</E> . <E T="03">Name of Committee:</E> Center for Scientific Review Special Emphasis Panel; Small Business: Radiation Therapy, Radiation Biology and Nanoparticle-Based Therapeutics Panel. <E T="03">Date:</E> November 18-19, 2025. <E T="03">Time:</E> 9:00 a.m. to 6:00 p.m. <E T="03">Agenda:</E> To review and evaluate grant applications. <E T="03">Address:</E> National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892. <E T="03">Meeting Format:</E> Virtual Meeting. <E T="03">Contact Person:</E> Michael M. Opata, Ph.D., Scientific Review Officer, NIH/NIAID, Immunology Review Branch, 5601 Fishers Lane, Room 3G22, Rockville, MD 20892, 240-627-3319, <E T="03">michael.opata@nih.gov</E> . (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) </EXTRACT> <SIG> <DATED>Dated: September 22, 2025.</DATED> <NAME>Sterlyn H Gibson, </NAME> Program Specialist, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-18625 Filed 9-24-25; 8:45 am]</FRDOC> </NOTICE>
This text is preserved for citation and comparison. View the official version for the authoritative text.